Puralube re-enters market
NEW YORK — Fera Pharmaceuticals on Wednesday announced the reintroduction of the nonprescription dry-eye remedy Puralube ophthalmic ointment due to demand for the product.
“Puralube is a product that fits perfectly with our eye care portfolio,” stated Frank DellaFera, president of Fera. “We are so pleased to make Puralube available again, giving patients, pharmacists and physicians a cost-effective and reliable treatment option for dry-eye symptoms.”
Fera is launching Puralube in a 3.5-g tube and a carton of 20 1-g tubes. It will be available through retail, wholesale and mail-order pharmacy, the company stated.